Germline mutation and large deletion analysis of the CDKN2A and ARF genes in families with multiple melanoma or an aggregation of malignant melanoma and breast cancer

No abstract is available for this paper.

• Publication year

  2004

• Venue

  International Journal of Cancer

• Publication date

  2004-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.20163PMID 15122588
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Germline 657del5 mutation in the NBS1 gene in patients with malignant melanoma of the skin

  2003cited by this paper
• Identification and characterization of genomic rearrangements of MSH2 and MLH1 in Lynch syndrome (HNPCC) by novel techniques

  2003cited by this paper
• Hereditary p16-Leiden mutation in a patient with multiple head and neck tumors.

  2003cited by this paper
• Germline 657del5 mutation in the NBS1 gene in breast cancer patients

  2003cited by this paper
• Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method.

  2003cited by this paper
• Increased risk of breast cancer in relatives of malignant melanoma patients from families with strong cancer familial aggregation

  2003cited by this paper
• Analysis of mutations in the p16/CDKN2A gene in sporadic and familial melanoma in the Polish population.

  2002cited by this paper
• Germline mutation of ARF in a melanoma kindred.

  2002cited by this paper
• An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele.

  2002cited by this paper
• A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family.

  2001cited by this paper
• Cancer risks in women with 2 breast or ovarian cancers: Clues to genetic cancer susceptibility

  2001cited by this paper
• A population-based study of familial cutaneous melanoma

  2001cited by this paper
• High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.

  2000cited by this paper
• Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status.

  2000cited by this paper
• The genetics of hereditary melanoma and nevi

  1999cited by this paper
• Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: A clinic‐based population study

  1998cited by this paper
• Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: a clinic-based population study.

  1998cited by this paper
• Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group.

  1998cited by this paper
• Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.

  1998cited by this paper
• Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis.

  1998cited by this paper
• Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma.

  1997cited by this paper
• Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.

  1996cited by this paper
• Familial cutaneous malignant melanoma and tumors of the nervous system

  1995cited by this paper
• Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene.

  1995cited by this paper
• Genetic epidemiology of familial melanoma.

  1995cited by this paper
• 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers

  1995cited by this paper
• Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations.

  1995cited by this paper
• A familial syndrome with cutaneous malignant melanoma and cerebral astrocytoma

  1993cited by this paper
• DNA isolation by a rapid method from human blood samples: Effects of MgCl2, EDTA, storage time, and temperature on DNA yield and quality

  1993cited by this paper
• Familial aggregation of melanoma, basal cell carcinoma, and gastric adenocarcinoma

  1986cited by this paper

• Deficiency of PTEN and CDKN2A Tumor-Suppressor Genes in Conventional and Chondroid Chordomas: Molecular Characteristics and Clinical Relevance

  2020cites this paper
• Identification of driver copy number alterations in diverse cancer types and application in drug repositioning

  2017cites this paper
• Two Cancers in One: Breast Carcinoma with Underlying Melanoma

  2017cites this paper
• Molecular portraits revealing the heterogeneity of breast tumor subtypes defined using immunohistochemistry markers

  2015cites this paper
• Familial melanoma: clinical factors associated with germline CDKN2A mutations according to the number of patients affected by melanoma in a family.

  2012cites this paper
• A study of matrix metalloproteinases in cancer and atherosclerosis.

  2012cites this paper
• Malignant melanoma and breast carcinoma: a bidirectional correlation

  2011cites this paper
• Genetic background of melanoma – results of own studies and the literature data

  2011cites this paper
• Selection criteria for genetic assessment of patients with familial melanoma.

  2009cites this paper
• Genomic rearrangements of the CDKN2A locus are infrequent in Italian malignant melanoma families without evidence of CDKN2A/CDK4 point mutations

  2008cites this paper
• Low prevalence of CDKN2A/ARF mutations among early-onset cancers of breast, pancreas and malignant melanoma in Poland

  2008cites this paper
• Germline CDKN2A/p16 mutations are rare in multiple primary and familial malignant melanoma in German patients.

  2008cites this paper
• The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma

  2008cites this paper
• CDKN2A-positive breast cancers in young women from Poland

  2007cites this paper
• Broad spectrum identification of SUMO substrates in melanoma cells

  2007cites this paper
• MELANOMA SUSCEPTIBILITY GENES AND THEIR ROLE IN CUTANEOUS MALIGNANT MELANOMA DEVELOPMENT IN LATVIA

  2007cites this paper
• Promoter SNPs in G1/S checkpoint regulators and their impact on the susceptibility to childhood leukemia.

  2007cites this paper
• A novel type of deletion in the CDKN2A gene identified in a melanoma‐prone family

  2006cites this paper
• CDKN2A common variant and multi‐organ cancer risk—a population‐based study

  2006cites this paper
• High- and low-penetrance cutaneous melanoma susceptibility genes

  2006cites this paper
• Fine allelotyping of Erbb2‐induced mammary tumors in mice reveals multiple discontinuous candidate regions of tumor‐suppressor loci

  2006cites this paper
• Familial risks and temporal incidence trends of multiple myeloma.

  2006cites this paper
• SHORT REPORT CDKN2A common variant and multi-organ cancer risk—a population-based study

  2006cites this paper
• CDKN 2 A common variant and multi-organ cancer risk — a population-based study

  2006cites this paper
• breast cancer A common variant of CDKN2A (p16) predisposes to

  2005cites this paper
• A common variant of CDKN2A (p16) predisposes to breast cancer

  2005cites this paper
• CDKN2A common variants and their association with melanoma risk: a population-based study.

  2005influential citation
• B‐RAF mutations in tumors from melanoma‐breast cancer families

  2005cites this paper
• CDKN 2 A Common Variants and Their Association with Melanoma Risk : A Population-Based Study

  2005cites this paper
• Familial Malignant Melanoma - Overview

  2004cites this paper